The objective of the study is to examine the efficacy and tolerability of a
three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's
compliance. The replacement therapy will be performed with a new Testosterone Gel examined in
previous trials as Testosteron Gel Wolff.